Avandamet
Avandamet® (rosiglitazone maleate/metformin HCl) is a new prescription medicine for treatment of type 2 diabetes. It is a single pill combining two popular diabetes medications. Avandamet® combines Rosiglitazone, known individually as Avandia® and Metformin HCl in a single pill to provide the combined action of the two medications in an easy to administer single dose. The two medications work in different ways to help patients who are being treated for type 2 diabetes. Rosiglitazone is said to make the body’s own insulin perform better, while Metformin HCl acts by lowering the liver’s production of sugar. Metformin HCl is the generic name of Glucophage®, and is a well known and widely accepted treatment for type 2 diabetes. Rosiglitazone maleate is the drug known more popularly as Avandia®, and it too is widely accepted for type 2 diabetes
treatment.
It is common for endocrinologists to prescribe either or both drugs along with diet and exercise as parts of a comprehensive treatment of type 2 diabetes, and Avandamet® is a prescription medication, which doctors might prefer to prescribe for patients who would otherwise be receiving both medications as part of their treatment.
Taking Avandamet® can cause or exacerbate fluid retention problems and can lead to weight gain, as well as heart problems. This new formulation contains Metformin therefore the warning about occasional reactions to the use of Metformin, including the possibility of developing lactic acidosis, which can be fatal, is repeated in the warnings pertaining to this medication. Additionally, a warning appears on the website stating that taking Avandamet® may cause heart failure. Avandament®, like all drugs for the control of diabetes type 2 requires monitoring of blood sugar as well as other health markers including liver and kidney function. As with all
prescription medications, always consult with your doctor for more information.
AVANDAMET NEWS HIGHLIGHTS
- FDA posts list of potential problem drugs
(AP) - FDA posts list of potential problem drugs
(AP) - Gastric stimulator induces weight loss in diabetics
(Reuters) - Consumer group asks government to ban Avandia
(AP) - School nurses help kids control diabetes
(Reuters) - Raptiva (efalizumab)
- Raptiva (efalizumab)
- ReliOn Insulin Syringes for use with U-100 Insulin (Tyco Healthcare – Covidien)
- ReliOn Insulin Syringes for use with U-100 Insulin (Tyco Healthcare – Covidien)
- Extended Therapy Helps Drug-Addicted Teens
(HealthDay) - Sitagliptin (marketed as Januvia and Janumet) – acute pancreatitis
- Sitagliptin (marketed as Januvia and Janumet) – acute pancreatitis
- AP IMPACT: Govt pays millions for unapproved drugs
(AP) - Studies do not link heart risk to bone drugs: FDA
(Reuters) - Tight Management of Type 1 Diabetes Worth the Effort
(HealthDay) - Aerobic, resistance best exercises for elderly
(Reuters) - Vets Often Forgo Medication When Co-Pays Rise
(HealthDay) - Artificial Pancreas Helps Type 1 Diabetics During Sleep
(HealthDay) - Artificial Pancreas Helps Type 1 Diabetics During Sleep
(HealthDay) - Glaxo defends handling of Avandia heart risks
(AP) - Glaxo defends handling of Avandia heart risks
(AP) - Doctors’ Guide to Cancer Drugs May Need Revising
(HealthDay) - Doctors’ Guide to Cancer Drugs May Need Revising
(HealthDay) - Doctors’ Guide to Cancer Drugs May Need Revising
(HealthDay) - Doctors’ Guide to Cancer Drugs May Need Revising
(HealthDay) - Doctors’ Guide to Cancer Drugs May Need Revising
(HealthDay) - ‘Fishy Smell’ May Keep Patients From Diabetes Drug
(HealthDay) - ‘Fishy Smell’ May Keep Patients From Diabetes Drug
(HealthDay) - Raptiva (efalizumab)
- ReliOn Insulin Syringes for use with U-100 Insulin (Tyco Healthcare – Covidien)
- Health Tip: Diabetics and Drinking
(HealthDay) - Avoiding the painkiller-overuse rut in migraines
(AP) - Avoiding the painkiller-overuse rut in migraines
(AP) - FDA Wants New Diabetes Drugs Tested for Heart Risks
(HealthDay) - Metformin can prevent postpartum diabetes
(Reuters) - Diabetic kids may focus too much on carb counting
(Reuters) - Diabetic kids may focus too much on carb counting
(Reuters) - FDA Wants New Diabetes Drugs Tested for Heart Risks
(HealthDay) - FDA Wants New Diabetes Drugs Tested for Heart Risks
(HealthDay) - Internet program helps diabetics monitor sugar
- Why Transplanted Insulin Cells Die
- Diabetes Drug Byetta: 6 Deaths Reported
- Manhattan Research Announces Top 10 Product Sites Visited By Physicians
- Aggressive diabetes control in very ill questioned
- LDL Cholesterol Tied to Increased Cancer Risk in Diabetics
- Early Weight Loss Could Help Control Type 2 Diabetes
- U-M Has Saved Medicare Money While Improving Treatment Of Heart And Diabetes Patients, Report Shows
- Combo of diabetes drugs may increase mortality
- Losing Weight Soon After Type 2 Diabetes Diagnosis Doubles Positive Outcomes
- Diabetic teens benefit from discussing problems